Clinical trial
68Ga FAPI in Total Neoadjuvant Therapy of Rectal Cancer
NCT06157463 is registered in ClinicalTrials.gov with Chang Gung Memorial Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 68Ga FAPI in Total Neoadjuvant Therapy of Rectal Cancer
- Lead sponsor
- Chang Gung Memorial Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- March 8, 2024
- Completion date
- July 31, 2028
- Enrollment
- 99 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rectal neoplasms malignant